US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
445 deals · US$333bndisclosed · Healthcare · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Aug 2026 | Alesta Therapeutics | – | BioMarin Pharmaceutical | Acquisition | Announced | 275.0 | Biotech+2 | J.P. Morgan (sell-side)Goodwin (sell-side)NautaDutilh (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side) |
| Aug 2026 | Weave Communications | – | Willow Parent, LLC (Francisco Partners) | Acquisition | Pending | 650.0 | Healthcare Software+2 | Jefferies (sell-side)Orrick (sell-side)Kirkland & Ellis (buy-side) |
| Aug 2026 | CheckedUp | Rockbridge Growth Equity | Providence Equity Partners | Acquisition | Announced | – | Advertising and marketing+2 | Debevoise & Plimpton (buy-side)Mintz (buy-side)Moelis & Company (sell-side)Greenberg Traurig (sell-side)Honigman (sell-side) |
| Aug 2026 | Meadowbrook at Agoura Hills | – | SlateView Capital | Asset sale | Announced | – | Real Estate+1 | Sidley Austin (buy-side) |
| Aug 2026 | Hicuity Health | – | DocGo | Acquisition | Announced | – | Healthcare Services+1 | TD Securities (sell-side)Stradling Yocca Carlson & Rauth (sell-side)Norton Rose Fulbright (buy-side) |
| Aug 2026 | Slate Medicines | – | Fulcrum Therapeutics | Merger | Announced | – | Biotech+1 | Goodwin (buy-side)Cooley (sell-side)Wedbush Securities (sell-side)Leerink Partners (buy-side) |
| Aug 2026 | Redx Pharma | – | Skye Bioscience | Acquisition | Announced | – | Biotech+1 | Wedbush Securities (sell-side)Cooley (sell-side)Stifel (buy-side)Morrison & Foerster (buy-side) |
| Aug 2026 | MAIN5 | – | Astrix | Acquisition | Announced | – | Pharma Services+1 | Gibson Dunn (buy-side) |
| Aug 2026 | Helix Advisory | – | EnableComp | Acquisition | Announced | – | Healthcare Software+1 | Greenberg Advisors (buy-side) |
| Aug 2026 | Actio Biosciences | – | Jazz Pharmaceuticals | Acquisition | Announced | 820.0 | Biotech+2 | J.P. Morgan (sell-side)Centerview Partners (sell-side)Cooley (sell-side)Moelis & Company (buy-side)Hogan Lovells Cadwalader (buy-side) |
| Aug 2026 | assets, business operations and customer relationships | – | NueCell Bio | Asset sale | Announced | – | Pharma Services+1 | Goodwin (buy-side) |
| Aug 2026 | Varex Imaging | – | Teledyne Technologies | Acquisition | Announced | 1,100.0 | Medtech+2 | Evercore (sell-side)Orrick (sell-side)Latham & Watkins (buy-side)McGuireWoods (buy-side) |
| Aug 2026 | Vital Connect | – | iRhythm Holdings | Acquisition | Announced | 287.5 | Medtech+1 | Goodwin (sell-side) |
| Aug 2026 | Smile America Partners | Beach Point Capital Management LP | – | Acquisition | Completed | – | Healthcare Services | Dechert (sell-side) |
| Aug 2026 | Cy Biopharma | – | Ensysce Biosciences | Acquisition | Completed | – | Biotech+1 | H.C. Wainwright & Co.Orrick (sell-side)Wedbush Securities (sell-side)Troutman Pepper Locke (buy-side)Tungsten Advisors (buy-side) |
| Aug 2026 | TYRVAYA (varenicline solution) nasal spray 0.03 mg | Viatris | Harrow | Asset sale | Announced | 30.0 | Pharma+1 | Cravath, Swaine & Moore (sell-side) |
| Aug 2026 | VitalConnect | – | iRhythm Holdings | Acquisition | Announced | 287.5 | Medtech | Goldman Sachs (buy-side)Fenwick & West (buy-side) |
| Aug 2026 | Alkeus Pharmaceuticals | – | Tarsus Pharmaceuticals | Acquisition | Announced | 450.0 | Biotech+2 | Jefferies (sell-side)Latham & Watkins (sell-side)Barclays (buy-side)Gunderson Dettmer (buy-side) |
| Aug 2026 | Lantheus Holdings | – | Curium US Holdings | Acquisition | Announced | 8,000.0 | Radiopharmaceuticals+1 | Morgan Stanley (sell-side)BofA Securities (sell-side)Solomon Partners (sell-side)Covington & Burling (sell-side)Ropes & Gray (sell-side)Jefferies (buy-side)J.P. Morgan (buy-side)PJT Partners (buy-side)Kirkland & Ellis (buy-side)Arnold & Porter (buy-side) |
| Aug 2026 | Supernus Pharmaceuticals | – | – | Merger | Announced | – | Pharma | Morgan Lewis (sell-side)Cantor Fitzgerald (sell-side)Wells Fargo Securities (sell-side)Saul Ewing (sell-side)Jefferies (buy-side)Piper Sandler (buy-side)Goodwin (buy-side)Citi (buy-side) |
| Aug 2026 | Integer Holdings | – | KKR | Acquisition | Announced | 5,700.0 | Medtech+2 | Raymond James (buy-side)Goldman Sachs (sell-side)Davis Polk (sell-side)Centerview Partners (buy-side)Barclays (buy-side)Citi (buy-side)Kirkland & Ellis (buy-side) |
| Aug 2026 | BWXT Medical business | BWX Technologies | Nordic Capital | Asset sale | Pending | 800.0 | Radiopharmaceuticals+2 | Solomon Partners (sell-side)Stikeman Elliott (sell-side)Kirkland & Ellis (buy-side)McCarthy Tétrault (buy-side) |
| Aug 2026 | AdaptHealth | – | – | Joint venture | Announced | – | Healthcare Services+1 | Guggenheim Securities |
| Aug 2026 | Relevate Health | Mountaingate Capital | – | Acquisition | Completed | – | Pharma Services+2 | Latham & Watkins (sell-side) |
| Aug 2026 | MIMETAS | – | BRUKER | Acquisition | Completed | – | Life Sciences+1 | Raymond James |
| Aug 2026 | KREWE Anesthesia | – | CHG Healthcare | Acquisition | Completed | – | Healthcare Staffing | Latham & Watkins (buy-side) |
| Aug 2026 | Numantec | – | Goldman Sachs Alternatives | Acquisition | Announced | – | Medtech+1 | Latham & Watkins (buy-side) |
| Aug 2026 | NovaBone Products | Halma | Isto Biologics | Acquisition | Completed | 60.0 | Medtech+1 | Baird (buy-side) |
| Aug 2026 | Teleflex Medical OEM | – | Montagu | Acquisition | Completed | 1,500.0 | Medtech+1 | Raymond James |
| Aug 2026 | Mindful Health Solutions | – | Radial Health | Acquisition | Completed | – | Behavioral Health | Edgemont Partners (sell-side) |
| Aug 2026 | Everlight Radiology | Livingbridge | Radiology Partners | Acquisition | Announced | – | Healthcare Services | Allens (sell-side)Linklaters (sell-side)Jones Day (buy-side) |
| Aug 2026 | Alafair Biosciences | – | Zimmer Biomet | Acquisition | Announced | 375.0 | Medtech | Guggenheim Securities (sell-side) |
| Jul 2026 | LogicMark | – | Langham Project | Merger | Announced | 1.5 | Consumer Electronics+1 | Roth Capital Partners (sell-side)Sullivan & Worcester (sell-side)Manatt, Phelps & Phillips (buy-side) |
| Jul 2026 | Neurimmune's royalty interest in AstraZeneca's cliramitug | Neurimmune | Royalty Pharma | Asset sale | Announced | 250.0 | Pharma+1 | Goodwin (buy-side) |
| Jul 2026 | Apex Infusion | – | SkyKnight Capital, L.P. | Stake | Announced | – | Healthcare Services | Willkie Farr & Gallagher (sell-side)Arnold & Porter (sell-side) |
| Jul 2026 | Synlogic | – | – | Merger | Announced | – | Biotech+1 | Lucid Capital Markets (sell-side)Mintz (sell-side)Fenwick & West (buy-side) |
| Jul 2026 | Avisoft Bioacoustics | – | Lafayette Instrument | Acquisition | Completed | – | Life Sciences+2 | Vedder Price (buy-side)RSM (buy-side) |
| Jul 2026 | Sanara MedTech | – | MiMedx Group | Acquisition | Announced | 350.0 | Medtech | Truist Securities (sell-side)Alston & Bird (sell-side)Centerview Partners (buy-side)Greenberg Traurig (buy-side) |
| Jul 2026 | MYOS Corp | – | PetIQ | Acquisition | Completed | – | Supplements+2 | Davis Graham (sell-side)Davis Polk (buy-side)Lincoln International (buy-side) |
| Jul 2026 | Vidya Therapeutics | – | Processa Pharmaceuticals | Acquisition | Completed | – | Biotech+1 | Leerink Partners (sell-side)Cooley (sell-side)Tungsten Advisors (buy-side)Katten Muchin Rosenman (buy-side) |
| Jul 2026 | Golden Gate Urology | – | – | Merger | Announced | – | Healthcare Services | |
| Jul 2026 | MAS Medical Staffing | – | Care Career | Acquisition | Completed | – | Healthcare Staffing+1 | The Braff Group (sell-side) |
| Jul 2026 | Forte Biosciences | – | argenx SE | Acquisition | Announced | 2,200.0 | Biotech+1 | Guggenheim Securities (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)Goldman Sachs (buy-side)Freshfields (buy-side)Innisfree M&A (buy-side) |
| Jul 2026 | OHB Pediatrics Ltd. d/b/a Oak Hill Bio | – | Research Alliance Corporation III | Merger | Announced | – | Biotech+2 | Goodwin (sell-side)Leerink Partners (buy-side)Cooley (buy-side) |
| Jul 2026 | KMM Group | – | RS2 Healthcare Partners | Acquisition | Completed | – | Contract Manufacturing+1 | Choate, Hall & Stewart (buy-side) |
| Jul 2026 | ArisGlobal | Nordic Capital | Dassault Systèmes | Acquisition | Announced | 2,000.0 | Healthcare Software+2 | Evercore (sell-side)Jefferies (sell-side)Kirkland & Ellis (sell-side)Sullivan & Cromwell (buy-side) |
| Jul 2026 | Neuphoria Therapeutics | – | Scancell Holdings | Acquisition | Announced | – | Biotech+1 | H.C. Wainwright & Co. (sell-side)WG Partners (sell-side)Winston Taylor (sell-side)Leerink Partners (buy-side)Cooley (buy-side) |
| Jul 2026 | The Skin Center | Footbridge Partners | – | Acquisition | Announced | – | Medical Aesthetics+1 | Mesirow (sell-side) |
| Jul 2026 | BioLife Solutions | – | Repligen | Acquisition | Announced | 1,500.0 | Life Sciences+1 | Centerview Partners (sell-side)K&L Gates (sell-side)Goodwin (buy-side)Perella Weinberg Partners (buy-side)Goldman Sachs (buy-side) |
| Jul 2026 | Northstar Dental Partners | – | Dentalcorp | Acquisition | Announced | – | Healthcare Services | Weil, Gotshal & Manges (buy-side) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built